APA (7th ed.) Citation

Z, X., X, Z., H, Q., X, A., K, W., X, L., . . . H, C. (2026). Pretreatment cardiometabolic risk in newly diagnosed breast cancer: A molecular subtype analysis. Frontiers in cardiovascular medicine, 13, 1835915. https://doi.org/10.3389/fcvm.2026.1835915

Chicago Style (17th ed.) Citation

Z, Xin, et al. "Pretreatment Cardiometabolic Risk in Newly Diagnosed Breast Cancer: A Molecular Subtype Analysis." Frontiers in Cardiovascular Medicine 13 (2026): 1835915. https://doi.org/10.3389/fcvm.2026.1835915.

MLA (9th ed.) Citation

Z, Xin, et al. "Pretreatment Cardiometabolic Risk in Newly Diagnosed Breast Cancer: A Molecular Subtype Analysis." Frontiers in Cardiovascular Medicine, vol. 13, 2026, p. 1835915, https://doi.org/10.3389/fcvm.2026.1835915.